The TEVAR Center

Filter Your Results

 

News

 

Ask the Experts: Should Clinically Asymptomatic Patients With Acute Type B Dissections and Radiographic Malperfusion Be Treated?

With Wilson Szeto, MD; Ibrahim Sultan, MD; Frank R. Arko III, MD; John R. Frederick, MD; Jocelyn K. Ballast, BA; and Christoph A. Nienaber, MD, PhD, FESC, FAHA

November 2016— Wilson Szeto, MD Professor of Surgery Chief, Cardiovascular Surgery Penn Presbyterian Medical Center Surgical Director Transcatheter Cardio-Aortic Therapies Associate

The Current State of Branched Stent Grafts for the Aortic Arch

Kira N. Long, MD, and Ross Milner, MD, FACS

November 2016—A review of five devices with investigational device exemptions in the United States.

Does It/Will It Work: Utility of Fusion Imaging for the Aortic Arch

Adrien Hertault, MD; Rachel Clough, MD, PhD; Thomas Modine, MD, PhD, MBA; Dominique Fabre, MD; Richard Azzaoui, MD; Jonathan Sobocinski, MD; and Stéphan Haulon, MD, PhD

November 2016—Current benefits of fusion imaging and potential future enhancements to aid in endovascular intervention.

Alternative Access Options for TEVAR

Christian C. Shults, MD; Frederick Tolle, BS; and Edward Y. Woo, MD

November 2016—Summary and review of current access methods for thoracic endovascular aneurysm repair.

Aberrant Right Subclavian Arteries

Tara M. Mastracci, MD, MSc, FRCSC, FACS, FRCS

November 2016—A review of the etiology, incidence, clinical presentation, and rationale for repair.

Gore Reaches Target Enrollment for GREAT Registry

November 15, 2016 -- Gore & Associates, Inc. announced today at the VEITHsymposium in New York, NY, that they have reached their target enrollment for the Global Registry …

An Interview With Lars Lönn, EBIR, FCIRSE

October 2016—Prof. Lönn shares his advice on critical aspects of TEVAR procedures, as well as the use of robotics and simulation training in endovascular therapies.

Three-Year Data Presented for Medtronic’s Valiant Captivia to Treat Acute Complicated Type B Aortic Dissections

September 20, 2016 -- Medtronic plc announced new data demonstrating safety and efficacy at 3 years in patients with acute complicated type B aortic dissection treated wi…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.